INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193,062 | +22.0% | 7,646 | +2.0% | 0.01% | +25.0% |
| Q2 2023 | $158,229 | +23.8% | 7,499 | 0.0% | 0.01% | +14.3% |
| Q1 2023 | $127,858 | -23.4% | 7,499 | -10.2% | 0.01% | 0.0% |
| Q4 2022 | $166,913 | +3.7% | 8,354 | +11.8% | 0.01% | -12.5% |
| Q3 2022 | $160,968 | +9.2% | 7,473 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $147,368 | -16.1% | 7,473 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $175,616 | -78.7% | 7,473 | -75.3% | 0.01% | -45.5% |
| Q4 2021 | $825,481 | -1.1% | 30,304 | 0.0% | 0.01% | -8.3% |
| Q3 2021 | $834,572 | -1.3% | 30,304 | +2.0% | 0.01% | 0.0% |
| Q2 2021 | $845,490 | -10.9% | 29,708 | +6.7% | 0.01% | -14.3% |
| Q1 2021 | $948,435 | -1.9% | 27,846 | -4.1% | 0.01% | 0.0% |
| Q4 2020 | $966,642 | +3.6% | 29,037 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $933,249 | +9.5% | 29,037 | -6.1% | 0.02% | +6.7% |
| Q2 2020 | $851,895 | +86.7% | 30,933 | +8.7% | 0.02% | +50.0% |
| Q1 2020 | $456,198 | -31.6% | 28,459 | +1.9% | 0.01% | -9.1% |
| Q4 2019 | $667,183 | +31.6% | 27,939 | -2.8% | 0.01% | +22.2% |
| Q3 2019 | $506,974 | -20.8% | 28,740 | +14.9% | 0.01% | -18.2% |
| Q2 2019 | $640,384 | -11.9% | 25,015 | 0.0% | 0.01% | -15.4% |
| Q1 2019 | $727,186 | +113.1% | 25,015 | -3.8% | 0.01% | +85.7% |
| Q4 2018 | $341,199 | -32.3% | 26,006 | +4.3% | 0.01% | -22.2% |
| Q3 2018 | $504,105 | -99.9% | 24,931 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $589,619,000 | +5.0% | 24,931 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $561,446,000 | +73969.4% | 24,931 | +2.5% | 0.01% | -20.0% |
| Q4 2017 | $758,000 | -50.4% | 24,316 | -50.4% | 0.01% | 0.0% |
| Q3 2017 | $1,529,000 | +102.0% | 48,976 | +11.0% | 0.01% | +100.0% |
| Q2 2017 | $757,000 | -2.1% | 44,137 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $773,000 | +29.5% | 44,137 | -2.2% | 0.01% | +25.0% |
| Q4 2016 | $597,000 | -6.9% | 45,122 | +2.3% | 0.00% | -20.0% |
| Q3 2016 | $641,000 | +47.4% | 44,127 | 0.0% | 0.01% | +66.7% |
| Q2 2016 | $435,000 | -22.2% | 44,127 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $559,000 | -30.2% | 44,127 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $801,000 | -2.2% | 44,127 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $819,000 | -25.9% | 44,127 | -2.5% | 0.01% | -25.0% |
| Q2 2015 | $1,106,000 | +35.4% | 45,272 | +15.2% | 0.01% | +33.3% |
| Q1 2015 | $817,000 | +34.4% | 39,301 | 0.0% | 0.01% | +50.0% |
| Q4 2014 | $608,000 | +18.5% | 39,301 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $513,000 | -10.6% | 39,301 | +36.8% | 0.00% | 0.0% |
| Q2 2014 | $574,000 | +4.9% | 28,722 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $547,000 | +11.9% | 28,722 | 0.0% | 0.00% | +33.3% |
| Q4 2013 | $489,000 | +9.2% | 28,722 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $448,000 | +57.7% | 28,722 | +21.0% | 0.00% | +50.0% |
| Q2 2013 | $284,000 | – | 23,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |